These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 32223926)
1. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING. Li YN; Su Y Biochem Biophys Res Commun; 2020 May; 526(2):381-388. PubMed ID: 32223926 [TBL] [Abstract][Full Text] [Related]
2. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. Qiao JT; Cui C; Qing L; Wang LS; He TY; Yan F; Liu FQ; Shen YH; Hou XG; Chen L Metabolism; 2018 Apr; 81():13-24. PubMed ID: 29106945 [TBL] [Abstract][Full Text] [Related]
3. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling. Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396 [TBL] [Abstract][Full Text] [Related]
4. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Wu L; Liu Y; Zhao Y; Li M; Guo L Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490 [TBL] [Abstract][Full Text] [Related]
5. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555 [TBL] [Abstract][Full Text] [Related]
6. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861 [TBL] [Abstract][Full Text] [Related]
7. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation. Pan ZG; An XS Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967 [TBL] [Abstract][Full Text] [Related]
8. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice. Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632 [TBL] [Abstract][Full Text] [Related]
9. Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-κB/HDAC3 signaling. Li Q; Ge C; Tan J; Sun Y; Kuang Q; Dai X; Zhong S; Yi C; Hu LF; Lou DS; Xu M Int Immunopharmacol; 2021 Jun; 95():107340. PubMed ID: 33667999 [TBL] [Abstract][Full Text] [Related]
10. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice. Hao YR; Tang FJ; Zhang X; Wang H Biochem Biophys Res Commun; 2018 Sep; 503(2):564-571. PubMed ID: 29852170 [TBL] [Abstract][Full Text] [Related]
11. Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress. Zilu S; Qian H; Haibin W; Chenxu G; Deshuai L; Qiang L; Linfeng H; Jun T; Minxuan X Aging (Albany NY); 2019 Dec; 11(24):12177-12201. PubMed ID: 31841118 [TBL] [Abstract][Full Text] [Related]
12. Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages. Cao L; Xu E; Zheng R; Zhangchen Z; Zhong R; Huang F; Ye J; Sun H; Fan Y; Xie S; Chen Y; Xu Y; Cao J; Cao W; Liu C Chin Med; 2022 Jan; 17(1):7. PubMed ID: 34983596 [TBL] [Abstract][Full Text] [Related]
13. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway. Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422 [TBL] [Abstract][Full Text] [Related]
14. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress. Li C; Liu Q; Xie L Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891 [TBL] [Abstract][Full Text] [Related]
15. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress. Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260 [TBL] [Abstract][Full Text] [Related]
16. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice. Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766 [TBL] [Abstract][Full Text] [Related]
17. Transmembrane protein 126B protects against high fat diet (HFD)-induced renal injury by suppressing dyslipidemia via inhibition of ROS. Weihong C; Bin C; Jianfeng Y Biochem Biophys Res Commun; 2019 Jan; 509(1):40-47. PubMed ID: 30580996 [TBL] [Abstract][Full Text] [Related]
18. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK. Wu YK; Hu LF; Lou DS; Wang BC; Tan J Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140 [TBL] [Abstract][Full Text] [Related]
19. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923 [TBL] [Abstract][Full Text] [Related]
20. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]